Financial Times US regulator approves at-home Alzheimer’s drug from Eisai and Biogen
Go ahead for Leqembi shot by Food and Drug Administration could help revive two companies’ sluggish sales
Go ahead for Leqembi shot by Food and Drug Administration could help revive two companies’ sluggish sales